PhaseRx Receives Decision from the Nasdaq Hearings Panel for Continued Listing of Shares PR Newswire SEATTLE, Dec. 13, 2017 SEATTLE, Dec. 13, 2017 /PRNewswire/ -- PhaseRx, Inc. (NASDAQ: PZRX), a...
PhaseRx Commences Voluntary Chapter 11 Bankruptcy Protection Proceeding PR Newswire SEATTLE, Dec. 11, 2017 SEATTLE, Dec. 11, 2017 /PRNewswire/ -- PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical...
PhaseRx Receives Positive Opinion for Orphan Drug Designation for PRX-ASL from European Medicines Agency PR Newswire SEATTLE, Nov. 28, 2017 SEATTLE, Nov. 28, 2017 /PRNewswire/ -- PhaseRx, Inc...
PhaseRx Reports Third Quarter 2017 Financial Results and Provides Corporate Update PR Newswire SEATTLE, Nov. 9, 2017 SEATTLE, Nov. 9, 2017 /PRNewswire/ -- PhaseRx, Inc. (NASDAQ: PZRX), a...
PhaseRx to Present at 5th International mRNA Conference PR Newswire SEATTLE, Oct. 31, 2017 SEATTLE, Oct. 31, 2017 /PRNewswire/ -- PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company...
PhaseRx Receives Delisting Notice from Nasdaq and Evaluates Listing Options PR Newswire SEATTLE, Oct. 26, 2017 SEATTLE, Oct. 26, 2017 /PRNewswire/ -- PhaseRx, Inc. (NASDAQ: PZRX), a...
PhaseRx Announces Corporate Restructuring and Review of Strategic Alternatives PR Newswire SEATTLE, Oct. 13, 2017 SEATTLE, Oct. 13, 2017 /PRNewswire/ -- PhaseRx, Inc. (NASDAQ: PZRX), a...
PhaseRx Receives Orphan Drug Designation from FDA for PRX-ASL for the Treatment of Argininosuccinate Lyase Deficiency PhaseRx's second enzyme replacement therapy to receive orphan drug...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 3006 | 1.0E-6 | CS |
26 | -0.000199 | -99.5 | 0.0002 | 0.0002 | 1.0E-6 | 1503 | 1.0E-6 | CS |
52 | -0.000199 | -99.5 | 0.0002 | 0.0002 | 1.0E-6 | 1503 | 1.0E-6 | CS |
156 | -9.9E-5 | -99 | 0.0001 | 0.0003 | 1.0E-6 | 2206 | 0.00010676 | CS |
260 | -0.001299 | -99.9230769231 | 0.0013 | 0.1 | 1.0E-6 | 17581 | 0.0145621 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.